China's rising demand for cooling doesn't have to drive rising temperatures. A recent study shows how rapid shifts to cleaner ...
Inovio Pharmaceuticals faces an October 30 PDUFA date for INO-3107 with high regulatory risk and only a 5-7 month cash runway. Read why INO stock is a hold.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback